inclusion criteria: 1. age of 19 years or older at the time of screening 2. those who have been confirmed covid-19 infection through pcr test 3. patients with mild or moderate covid-19 who meet national ews (0\~6) 4. those who have given written consent and voluntarily decided to participate before the screening procedure after understanding the detailed description of the clinical trial. 5. those who are suitable as subjects for this clinical study when judged by physical examination, clinical laboratory test, and other medical examination as stated in the flowchart of protocol.

inclusion criteria: 1. age of 19 years or older at the time of screening 2. those who have been confirmed covid-19 infection through pcr test 3. patients with mild or moderate covid-19 who meet national ews (0\~6) 4. those who have given written consent and voluntarily decided to participate before the screening procedure after understanding the detailed description of the clinical trial. 5. those who are suitable as subjects for this clinical study when judged by physical examination, clinical laboratory test, and other medical examination as stated in the flowchart of protocol.

inclusion criteria: age of 19 years or older at the time of screening those who have been confirmed covid-19 infection through pcr test patients with mild or moderate covid-19 who meet national ews (0~6) those who have given written consent and voluntarily decided to participate before the screening procedure after understanding the detailed description of the clinical trial. those who are suitable as subjects for this clinical study when judged by physical examination, clinical laboratory test, and other medical examination as stated in the flowchart of protocol.

inclusion criteria: age of 19 years or older at the time of screening those who have been confirmed covid-19 infection through pcr test patients with mild or moderate covid-19 who meet national ews (0~6) those who have given written consent and voluntarily decided to participate before the screening procedure after understanding the detailed description of the clinical trial. those who are suitable as subjects for this clinical study when judged by physical examination, clinical laboratory test, and other medical examination as stated in the flowchart of protocol.

inclusion criteria: 1. age of 19 years or older at the time of screening 2. those who have been confirmed covid-19 infection through pcr test 3. patients with mild or moderate covid-19 who meet national ews (0~6) 4. those who have given written consent and voluntarily decided to participate before the screening procedure after understanding the detailed description of the clinical trial. 5. those who are suitable as subjects for this clinical study when judged by physical examination, clinical laboratory test, and other medical examination as stated in the flowchart of protocol.

inclusion criteria: 1. age of 19 years or older at the time of screening 2. those who have been confirmed covid-19 infection through pcr test 3. patients with mild or moderate covid-19 who meet national ews (0~6) 4. those who have given written consent and voluntarily decided to participate before the screening procedure after understanding the detailed description of the clinical trial. 5. those who are suitable as subjects for this clinical study when judged by physical examination, clinical laboratory test, and other medical examination as stated in the flowchart of protocol.